**Question:** Chronic granulocytic leukemia is due to

A. Chronic phase
B. Chronic myeloid leukemia
C. Myeloproliferative disorder
D. Myelodysplastic syndrome

**Core Concept:** Chronic granulocytic leukemia (CGL) is a type of blood cancer characterized by the uncontrolled proliferation of granulocytes, a type of white blood cell. Chronic myeloid leukemia (CML) is a specific type of CGL, which is caused by the Philadelphia chromosome - a reciprocal chromosomal translocation between chromosomes 9 and 22, resulting in the fusion of BCR and ABL genes.

**Why the Correct Answer is Right:** Chronic myeloid leukemia (CML) is a type of chronic granulocytic leukemia (CGL), which is caused by a specific genetic mutation (Philadelphia chromosome). The Philadelphia chromosome results from the fusion of two genes, BCR and ABL, leading to the production of a constitutively active tyrosine kinase protein that promotes uncontrolled proliferation of granulocytes, the primary cell type affected in CGL.

**Why Each Wrong Option is Incorrect:**

A. Chronic phase (CML): This is a phase in the disease progression, not a cause. CML progresses through three phases: chronic, accelerated, and blast crisis. The correct answer (CML) is the cause, not the phase.

B. Chronic myeloproliferative disorder: This is a general term for a group of blood disorders characterized by uncontrolled proliferation of one or more types of blood cells. While CML is a chronic myeloproliferative disorder, it is specifically caused by the Philadelphia chromosome and BCR-ABL fusion gene, making CML the correct answer.

C. Myelodysplastic syndrome: This is a group of blood disorders characterized by ineffective hematopoiesis and dysplastic changes in one or more types of blood cells. CML is not a myelodysplastic syndrome but a Philadelphia chromosome-driven myeloproliferative disorder.

D. Myeloproliferative disorder: Similar to Option B, this is a broad term for a group of blood disorders characterized by uncontrolled proliferation of one or more types of blood cells. CML is a specific example of a myeloproliferative disorder, but the cause of CML is the Philadelphia chromosome and BCR-ABL fusion gene, making CML the correct answer.

**Clinical Pearl:** The Philadelphia chromosome is a specific chromosomal abnormality that occurs in CML, characterized by the fusion of BCR and ABL genes. This chromosomal abnormality leads to the production of a constitutively active tyrosine kinase protein, which promotes uncontrolled proliferation of granulocytes (granulocytes) and causes the characteristic features of CML, including splenomegaly, leukocytosis, and cytopenias. Understanding the genetic cause (Philadelphia chromosome) and the resulting protein (BCR-ABL fusion protein) is essential for understanding the pathogenesis of CML and differentiating it from other myeloproliferative disorders with similar clinical features.